Skip to content
PharmCADD logo — PharmCADD is a company designed to accelerate drug discovery...

PharmCADD

PharmCADD is a company designed to accelerate drug discovery using technologies of AI and Molecular Dynamics Simulation.

Founded 2019 Korea South Korea South 16 employees Series B Total: $1.02B AI, Biotechnology +1

General Information

Company Name PharmCADD
Founded Year 2019
Location Korea South Korea South
Employees 16
Industries AI, Biotechnology, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with PharmCADD. To contact PharmCADD, visit pharmcadd.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does PharmCADD compare?

A PDF of PharmCADD and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting PharmCADD soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About PharmCADD

PharmCADD, founded in 2019 and headquartered in Korea South, is leveraging state-of-the-art technologies to revolutionize drug discovery. The company combines Artificial Intelligence (AI), Molecular Dynamics (MD), Quantum Calculation (QC), and Network Theory to enhance both the speed and accuracy of discovering new drugs. Their approach significantly reduces the need for maintaining costly infrastructure associated with traditional high-performance computational resources.

The integration of data-derived AI with physics-based MD and QC technologies provides a competitive edge, allowing PharmCADD to precisely characterize drug candidates amidst a sprawling chemical landscape. This tech-driven approach aligns perfectly with current industry trends, positioning the company as a potentially transformative player in the AI, Biotechnology, and Pharmaceutical sectors.

With a recent $16.00M Series B investment on April 19, 2021, which included financiers like DSC Investment and KTB Network, PharmCADD is poised for further growth and innovation in its mission to streamline drug discovery.

Business keywords: AI Drug Discovery, Molecular Dynamics Simulation, Quantum Calculation, Protein Structure Prediction, Virtual Screening, Toxicity Prediction, Drug Generation Platform, RNA Structure Prediction, Computational Pharmacology, Vaccine Development, AI in Healthcare, Pharmaceutical Innovation, High-Performance Computational Resources, Network Theory in Drug Discovery, Chemical Space Exploration

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $16.00M 10
DSC Investment, KTB Network +8
01 Apr 2021
Series A KRW1.00B -
01 Jun 2020
Seed Undisclosed -
01 Jul 2019
Spinout Undisclosed 1
Pukyong National University
01 Jan 2019

PharmCADD Alternatives & Competitors

View All Alternatives
PharmCADD vs

Unifying AI and Biotech to accelerate the discovery of new medicines

157 employees
AI, Biotechnology
PharmCADD vs
XtalPi Inc.
XtalPi Inc. United States

Dedicated to building a technology platform using AI and robotics to drive innovation in multiple in...

IPO
398 employees
Biotechnology, Pharmaceutical
PharmCADD vs

HTuO Biosciences is a drug discovery company that works at the interface of physics, chemistry, & co...

22 employees
Biotechnology, Pharmaceutical

FAQ About PharmCADD

PharmCADD is a company designed to accelerate drug discovery using technologies of AI and Molecular Dynamics Simulation.
PharmCADD was founded in 2019.
PharmCADD is headquartered in Korea South.
PharmCADD operates in AI, Biotechnology and Pharmaceutical. Its work centres on AI Drug Discovery, Molecular Dynamics Simulation, Quantum Calculation and Protein Structure Prediction.
PharmCADD has approximately 16 employees.
PharmCADD has completed 4 funding rounds, raising a total of $1.02B. The latest funding stage is Series B.
Top alternatives and competitors to PharmCADD include Genesis Molecular AI, XtalPi Inc., HTuO Biosciences, Galux, biosimulytics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PharmCADD and Genesis Molecular AI are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PharmCADD, https://www.bouncewatch.com/company/pharmcadd, updated 15 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout